We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.1M
AUM Growth
-$17.9M
Cap. Flow
-$4.42M
Cap. Flow %
-7.61%
Top 10 Hldgs %
43.93%
Holding
340
New
63
Increased
59
Reduced
56
Closed
151

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
+$2.31M
2
AMGN icon
Amgen
AMGN
+$1.97M
3
IBB icon
iShares Biotechnology ETF
IBB
+$1.79M
4
TSRO
TESARO, Inc.
TSRO
+$1.56M
5
CLX icon
Clorox
CLX
+$1.3M

Top Sells

1
ABT icon
Abbott
ABT
+$5.02M
2
AKBA icon
Akebia Therapeutics
AKBA
+$3.63M
3
FL
Foot Locker
FL
+$2.12M
4
GIS icon
General Mills
GIS
+$2.03M
5
LULU icon
lululemon athletica
LULU
+$1.38M

Sector Composition

1 Healthcare 37.51%
2 Consumer Staples 17.11%
3 Consumer Discretionary 2.69%
4 Communication Services 1.36%
5 Materials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
101
CALL
Coca-Cola
KO
$365B
$62K 0.11%
130,000
-59,500
-31% -$2.63M
AMGN icon
102
PUT
Amgen
AMGN
$201B
$60K 0.1%
19,900
+7,300
+58% +$1.19M
SIOX
103
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$60K 0.1%
3,700
+3,437
+1,307% +$602K
LULU icon
104
CALL
lululemon athletica
LULU
$13.5B
$59K 0.1%
17,100
-32,000
-65% -$1.67M
CPB icon
105
Campbell Soup
CPB
$6.75B
$57K 0.1%
+1,100
New +$62.3K
CPB icon
106
PUT
Campbell Soup
CPB
$6.75B
$55K 0.09%
+10,000
New +$566K
GBT
107
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$54K 0.09%
+20,000
New +$595K
BHC icon
108
PUT
Bausch Health
BHC
$1.84B
$53K 0.09%
35,000
+15,000
+75% +$180K
PEP icon
109
CALL
PepsiCo
PEP
$190B
$52K 0.09%
56,400
-71,600
-56% -$8.21M
HSY icon
110
PUT
Hershey
HSY
$35.4B
$50K 0.09%
+6,800
New +$750K
GBT
111
DELISTED
Global Blood Therapeutics, Inc.
GBT
$49K 0.08%
+1,805
New +$53.7K
DIS icon
112
PUT
Walt Disney
DIS
$173B
$48K 0.08%
5,000
-30,000
-86% -$3.29M
ISRG icon
113
CALL
Intuitive Surgical
ISRG
$142B
$46K 0.08%
+13,500
New +$1.3M
AGN
114
CALL
DELISTED
Allergan plc
AGN
$46K 0.08%
+7,500
New +$1.76M
KMB icon
115
CALL
Kimberly-Clark
KMB
$36.2B
$45K 0.08%
15,000
-12,000
-44% -$1.56M
GIS icon
116
CALL
General Mills
GIS
$20.7B
$43K 0.07%
124,000
+17,800
+17% +$1.02M
AERI
117
PUT
DELISTED
Aerie Pharmaceuticals
AERI
$43K 0.07%
+15,000
New +$698K
ZYNE
118
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$42K 0.07%
+2,500
New +$49.7K
STZ icon
119
PUT
Constellation Brands
STZ
$23.2B
$41K 0.07%
10,000
-9,000
-47% -$1.6M
GWPH
120
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$41K 0.07%
9,100
– –
CLX icon
121
CALL
Clorox
CLX
$11.9B
$40K 0.07%
25,200
-37,500
-60% -$5.06M
ISRG icon
122
PUT
Intuitive Surgical
ISRG
$142B
$40K 0.07%
77,400
+49,500
+177% +$4.76M
RCKT icon
123
PUT
Rocket Pharmaceuticals
RCKT
$372M
$39K 0.07%
+7,825
New +$58.3K
SIOX
124
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$39K 0.07%
375
-813
-68% -$143K
BCRX icon
125
PUT
BioCryst Pharmaceuticals
BCRX
$2.31B
$38K 0.07%
+15,000
New +$91.4K
3 4
5
6 7

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q2 2017 Portfolio in Review

As of Q2 2017, FT Options held 340 positions worth $58.1M, down 24% from $76M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $4.42M in Q2 2017, closing 151 positions and reducing 56 holdings. Its most notable exit was Foot Locker, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Amgen worth $2.08M.

  • FT Options's largest Q2 2017 buy was Amgen: 12,082 shares worth $2.08M.
  • FT Options added most to Clovis Oncology, Inc. in Q2 2017, an estimated $2.31M increase.
  • FT Options's biggest Q2 2017 reduction was Abbott, cutting an estimated $5.02M.
  • FT Options fully exited Foot Locker in Q2 2017, selling an estimated $2.12M.
  • FT Options's ten largest holdings make up 44% of its $58.1M portfolio in Q2 2017.
  • FT Options opened 63 new positions and closed 151 in Q2 2017.
  • FT Options's portfolio value fell 24% quarter-over-quarter to $58.1M.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.